{"id":"NCT01020487","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)","officialTitle":"A Phase 3, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Intact Parathyroid Hormone Levels in Pediatric Subjects Ages 10 to 16 Years With Moderate to Severe Chronic Kidney Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2014-05","completion":"2014-12","firstPosted":"2009-11-24","resultsPosted":"2017-03-29","lastUpdate":"2018-07-02"},"enrollment":47,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Kidney Disease Stage 3 and 4"],"interventions":[{"type":"DRUG","name":"Paricalcitol","otherNames":["Zemplar"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Part 1: Paricalcitol","type":"EXPERIMENTAL"},{"label":"Part 2: Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Part 2: Paricalcitol","type":"EXPERIMENTAL"}],"summary":"Part 1: To determine the safety, tolerability, and pharmacokinetics of a single dose of 3 Î¼g paricalcitol capsules in children ages 10 to 16 years with moderate to severe chronic kidney disease (CKD Stages 3 and 4).\n\nPart 2: To determine the safety and efficacy of paricalcitol capsules as compared to placebo in decreasing serum intact parathyroid hormone (iPTH) in children ages 10 to 16 years with moderate to severe chronic kidney disease with an initial 12 weeks of double-blinded study drug followed by a minimum of 12 weeks of open-label active drug.","primaryOutcome":{"measure":"Part 1: Paricalcitol Maximum Observed Plasma Concentration (Cmax)","timeFrame":"Blood samples were collected at hour 0, 1, 2, 4, 6, 8, 12, 24, 36, and 48 hours after dosing.","effectByArm":[{"arm":"Part 1: Paricalcitol","deltaMin":0.13,"sd":0.052}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28332096"],"seeAlso":["http://www.rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["HYPERCALCAEMIA","NASOPHARYNGITIS","HYPERKALAEMIA","HEADACHE","NAUSEA"]}}